SFPIA
VYNT

Stevens First Principles Investment Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed -$12K – 240
2015
Q2 		$12K Hold
7
– – 0.01% 191
2015
Q1 		$8K Buy
+7
New +$8.29K 0.01% 191
2014
Q1 		– Sell
-5
Closed -$11K – 225
2013
Q4 		$11K Buy
+5
New +$10.8K 0.01% 183

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Stevens First Principles Investment Advisors's VYNT Position: Q3 2015 in Review

Stevens First Principles Investment Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2015, closing a stake of 7 shares — an estimated $12K sold.

Stevens First Principles Investment Advisors first reported a position in VYNT in Q4 2013 and held it in 3 quarters. The position peaked at $12K in Q2 2015. 32 funds tracked by Wall St. Rank hold VYNT as of Q3 2015.

  • Stevens First Principles Investment Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 7 Vyant Bio, Inc. Common Stock shares in Q3 2015, an estimated $12K.
  • Stevens First Principles Investment Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • Stevens First Principles Investment Advisors's Vyant Bio, Inc. Common Stock position peaked at $12K in Q2 2015.
  • 32 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.